Brief: Adial Pharmaceuticals Granted End Of Phase 2 Meeting From FDA

Azora Therapeutics

08/05/2025 16:03

May 8 (Reuters) - Adial Pharmaceuticals Inc ADIL.O:

ADIAL PHARMACEUTICALS GRANTED END OF PHASE 2 MEETING FROM THE U.S. FOOD AND DRUG ADMINISTRATION

ADIAL PHARMACEUTICALS INC - FDA MEETING SCHEDULED FOR JULY 25, 2025

Source text: ID:nGNX53XlvP

Further company coverage: ADIL.O

 ((Reuters.Briefs@thomsonreuters.com))